Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics - 5 Apr 2007

Tadić André, Müller Matthias J, Rujescu Dan, Kohnen Ralf, Stassen Hans H, Dahmen Norbert, Szegedi Armin

Abstract excerpt

This study investigated the possible association of the MAOA T941G gene variant with differential antidepressant response to mirtazapine and/or paroxetine in 102 patients with major depression (DSM-IV criteria) participating in a randomized double-blind controlled clinical trial. Female mirtazapine-treated patients homozygous for the T-allele had a significantly faster and better treatment response than...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Double-Blind Method

Share to Genetic Linkage

Share to Monoamine Oxidase

Share to Paroxetine

Share to Sex Characteristics

Share to Treatment Outcome

Source

Identifiers

PMID: 17192957
DOI: 10.1002/ajmg.b.30462

Genes

MAOA

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.PMID 17192957Read ↗

A monoamine oxidase B gene variant and short-term antidepressant treatment response.Semantic proximity Read ↗

MAOA gene polymorphisms and response to mirtazapine in major depressionSemantic proximity Read ↗

Monoamine oxidase A variant influences antidepressant treatment response in female patients with Major Depression.Semantic proximity Read ↗

Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression.Semantic proximity Read ↗

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.Semantic proximity Read ↗

Serotonin transporter polymorphism and bleeding time during SSRI therapy.Semantic proximity Read ↗

Is 5-HTTLPR linked to the response of selective serotonin reuptake inhibitors in MDD?Semantic proximity Read ↗

Association study of the serotonin transporter promoter polymorphism and mirtazapine antidepressant response in major depressive disorder.Semantic proximity Read ↗

Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene.Semantic proximity Read ↗

Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder.Semantic proximity Read ↗

No support for a role for BDNF gene polymorphisms rs11030101 and rs61888800 in major depressive disorder or antidepressant response in patients of Finnish origin.Semantic proximity Read ↗

Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.